Brief: MiNK Therapeutics Regains Full Compliance With Nasdaq Listing Requirements
20/02/2025 13:32
Feb 20 (Reuters) - Mink Therapeutics Inc INKT.O :
* MINK THERAPEUTICS REGAINS FULL COMPLIANCE WITH NASDAQ
LISTING
REQUIREMENTS
Source text: ID:nGNX1Qtvcf
Further company coverage: INKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's